Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A structured narrative review synthesizing evidence on AI across obesity management pathways, finding limited direct patient-level evidence for AI-specific effects and recommending AI as a clinical augmentation tool pending further validation.
Genome-wide CRISPR screening in cell lines identifies candidate genes regulating interferon induction, providing mechanistic insights and a resource for future studies but not clinical evidence of efficacy or causation in disease.
This is an unreviewed preprint reporting a novel method (TAILS) with experimental validation across continual learning benchmarks, but lacks peer review, clinical translation, and independent replication.